Asian Eye Institute offers retinal injection procedures as part of our advanced treatment options for various conditions that affect the retina, such as age-related macular degeneration, macular edema, and diabetic retinopathy. In this procedure, a skilled professional injects medication directly into the vitreous or the gel-like substance inside the eye.
Experience world-class treatment under our care.
Eye injections are effective in treating various retinal conditions. It is a precise approach that administers accurate doses of medications directly to the vitreous cavity of the eye, allowing us to target issues directly. Each injection may contain anti-VEGF drugs to lessen fluid leakage, steroids to reduce inflammation, and antibiotics to treat infections.
Retinal injections are typically performed in an outpatient setting. A trained specialist numbs the eye first before administering the injection into the vitreous to deliver the prescribed medication. Patients may feel some pressure and discomfort, but the procedure is generally considered safe with a high success rate.
To manage age-related macular degeneration, ophthalmologists recommend intravitreal injections. These deliver anti-VEGF medications like Ranibizumab or Aflibercept directly into the eye, reducing abnormal blood vessel growth and fluid buildup. This targeted method helps preserve vision and slow disease progression more effectively than oral or topical treatments. Administered regularly, it offers many patients a chance to maintain clear central vision.
Macular edema, a leading cause of central vision impairment, can be effectively managed through intravitreal injections. This procedure delivers anti-VEGF medications like Aflibercept or Ranibizumab directly into the eye to reduce fluid buildup and retinal swelling. These drugs block vascular endothelial growth factor (VEGF), which drives the fluid leakage that causes vision loss.
As one of the most common causes of vision loss among individuals with diabetes, diabetic retinopathy requires timely and targeted intervention. This sight-saving procedure uses anti-VEGF medications such as Bevacizumab or Ranibizumab to prevent abnormal blood vessel growth and reduce retinal bleeding or swelling. It helps preserve and even restore vision in diabetic patients.
The injected drugs inhibit VEGF activity, which is heightened in diabetes and contributes to progressive retinal damage.
Anti-VEGF medications block a protein called VEGF, which triggers abnormal blood vessel growth in the eye. Intravitreal injections deliver the medication into the eye, helping reduce swelling, stop further damage to the retina, and preserve vision in conditions like macular degeneration and diabetic eye disease.
Intravitreal injections are used to manage different conditions, so you may need to get them multiple times. The frequency depends on your condition and your eyes’ response. This will be assessed by your ophthalmologist.
During the procedure, you will receive a local anesthetic to minimize the pain. Most of our patients report little to no pain, only a slight discomfort that subsides immediately after the procedure.
While intravitreal injections are generally safe, mild side effects like temporary eye irritation or small dark shapes moving across your field of vision (floaters) may occur. Rare complications include infection or retinal detachment. However, these risks are minimized by strict sterile techniques and expert administration. For most patients, the benefits of protecting vision far outweigh the risks, making this procedure a trusted, effective option for managing macular degeneration.
Most people can return to normal activities just one day after the procedure. However, any mild side effects or discomfort should completely subside after one week.
If you experience any pain, decreased vision, floaters, or continued discomfort, please contact us right away so we can assess and address the complication immediately.
